CBUS vs. AVD, LFVN, NAII, CGA, EVGN, MTEX, BIOX, LWAY, LMNR, and MED
Should you be buying Cibus stock or one of its competitors? The main competitors of Cibus include American Vanguard (AVD), LifeVantage (LFVN), Natural Alternatives International (NAII), China Green Agriculture (CGA), Evogene (EVGN), Mannatech (MTEX), Bioceres Crop Solutions (BIOX), Lifeway Foods (LWAY), Limoneira (LMNR), and Medifast (MED).
Cibus (NASDAQ:CBUS) and American Vanguard (NYSE:AVD) are both small-cap consumer staples companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk, profitability and community ranking.
Cibus has a beta of 1.92, indicating that its stock price is 92% more volatile than the S&P 500. Comparatively, American Vanguard has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.
American Vanguard received 289 more outperform votes than Cibus when rated by MarketBeat users. However, 100.00% of users gave Cibus an outperform vote while only 61.26% of users gave American Vanguard an outperform vote.
American Vanguard has a net margin of 1.30% compared to Cibus' net margin of -14,729.06%. American Vanguard's return on equity of 2.05% beat Cibus' return on equity.
33.8% of Cibus shares are owned by institutional investors. Comparatively, 79.0% of American Vanguard shares are owned by institutional investors. 4.4% of Cibus shares are owned by company insiders. Comparatively, 9.3% of American Vanguard shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, American Vanguard had 1 more articles in the media than Cibus. MarketBeat recorded 2 mentions for American Vanguard and 1 mentions for Cibus. American Vanguard's average media sentiment score of 0.20 beat Cibus' score of 0.00 indicating that American Vanguard is being referred to more favorably in the news media.
American Vanguard has higher revenue and earnings than Cibus. Cibus is trading at a lower price-to-earnings ratio than American Vanguard, indicating that it is currently the more affordable of the two stocks.
Cibus currently has a consensus price target of $25.00, indicating a potential upside of 47.58%. American Vanguard has a consensus price target of $18.00, indicating a potential upside of 54.44%. Given American Vanguard's higher probable upside, analysts clearly believe American Vanguard is more favorable than Cibus.
Summary
American Vanguard beats Cibus on 14 of the 17 factors compared between the two stocks.
Get Cibus News Delivered to You Automatically
Sign up to receive the latest news and ratings for CBUS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CBUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
